Implanet S.A. (FRA:IM11)

Market Cap	25.50M +94.3%
Revenue (ttm)	12.47M +52.1%
Net Income	-4.38M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3,404
Open	0.2010
Previous Close	0.2010
Day's Range	0.2010 - 0.2010
52-Week Range	0.0768 - 0.4280
Beta	n/a
RSI	42.19
Earnings Date	Sep 15, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S....

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Employees: 46
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IM11

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.